Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/1999
06/16/1999EP0922462A2 Process for preparation of solid dosage forms
06/16/1999EP0922457A1 Skin protection composition
06/16/1999EP0922453A2 Percutaneous absorption type preparation containing tulobuterol
06/16/1999EP0922451A2 Microcapsules containing seminal material for artificial insemination in pigs
06/16/1999EP0922450A1 Effervescent preparation containing a plant extract
06/16/1999EP0922449A2 Use of an enzymatically converted starch derivative as an encapsulating agent
06/16/1999EP0922071A1 Polycarboxylic based cross-linked copolymers
06/16/1999EP0921812A1 INSULIN PREPARATIONS CONTAINING NaCl
06/16/1999EP0921811A2 Administration of histamine for therapeutic purposes
06/16/1999EP0921810A2 Method of reducing the severity of host vs. graft reaction by down-regulating hsp60 autoimmunity
06/16/1999EP0921808A1 Non-aqueous polar aprotic peptide formulations
06/16/1999EP0921807A1 Hydrogenous medicament
06/16/1999EP0921806A1 Mannose-6-phosphate composition and its use in treating fibrotic disorders
06/16/1999EP0921796A1 Tetrahydrolipstatin containing compositions
06/16/1999EP0921795A1 An aqueous formulation comprising bambuterol and the use thereof
06/16/1999EP0921793A1 Solid, non-deliquescent formulations of sodium valproate
06/16/1999EP0921789A1 Taste masked liquid suspensions
06/16/1999EP0921787A1 ADMINISTRATION REGIMEN OF H+,K+-ATPase INHIBITORS
06/16/1999EP0921786A1 Nasal administration of desmopressin
06/16/1999EP0921774A1 Transdermal drug delivery matrix for coadministering estradiol and another steroid
06/16/1999EP0921756A1 Novel radiopharmaceutical compositions and matrices and uses thereof
06/16/1999EP0873127A4 Anthelmintic macrocyclic lactone compositions
06/16/1999EP0848736A4 Acid resistant calcium carbonate composition containing an aluminum salt and uses therefor
06/16/1999EP0836495A4 Delivery of oxygen-supersaturated physiologic solutions
06/16/1999EP0689415B1 Low-viscosity cosmetic and pharmaceutical emulsions
06/16/1999EP0581842B1 An organ specific emulsion
06/16/1999CN2323783Y Nifedipine plaster film
06/16/1999CN2323782Y Constant release paster for metoprolol
06/16/1999CN2323781Y Order arrangement feeding apparatus for capsule
06/16/1999CN1219967A Glial cell line-derived neurotrophic factor receptor
06/16/1999CN1219924A Colchicine-skeleton compounds, their use as medicaments and compounds containing them
06/16/1999CN1219919A Dissolvable oxides for biological applications
06/16/1999CN1219879A Pharmaceutical compositions
06/16/1999CN1219874A Preparation for percutaneous administration
06/16/1999CN1219872A Compositions and method for treating or preventing diseases of body passageways
06/16/1999CN1219429A Baby's mother health granulae and its processing method
06/16/1999CN1219427A Local external-mounted medicament for curing angiitis and its preparation method
06/16/1999CN1219426A Local external-mounted medicament for curing fracture and its preparation method
06/16/1999CN1219424A Dandelion series health-care products
06/16/1999CN1219422A Medicine for curing hepatic and gallbladder diseases
06/16/1999CN1219420A External protection medicine for preventing schistosoma miracidium infection
06/16/1999CN1219419A Cat-tail pollen pill
06/16/1999CN1219411A Soft extract for relieving cough and asthma and its preparation method
06/16/1999CN1219408A Capsule for tranquilization and vitalization
06/16/1999CN1219401A Seahorse pain-eliminating ointment
06/16/1999CN1219396A Gushifu-external application medicine for curing wind-cold syndrome
06/16/1999CN1219393A Veterinary antiparasitic oil preparation oral liquid containing avilamycin or ivermectin
06/16/1999CN1219391A Choline antagonist sticking preparation
06/16/1999CN1219388A Comedo-extracting plastering sheet
06/16/1999CN1043609C Process for preparing pharmaceutical composition containing benzothiazole compounds
06/15/1999US5912330 Sweeteners
06/15/1999US5912271 Local anaesthetic agents, a polar lipid, a triacylglycerol and optionally water.
06/15/1999US5912268 Dosage form and method for treating incontinence
06/15/1999US5912239 Imidazole-containing cationic amphiphiles for intracellular delivery of therapeutic molecules
06/15/1999US5912225 Biodegradable poly (phosphoester-co-desaminotyrosyl L-tyrosine ester) compounds, compositions, articles and methods for making and using the same
06/15/1999US5912017 Multiwall polymeric microspheres
06/15/1999US5912016 Particles of crosslinked plant proteins and the process for their preparation
06/15/1999US5912015 Drug delivery using time-release agent having zinc or magnesium salt dispersed in matrix; biodegradable
06/15/1999US5912014 Oral salmon calcitonin pharmaceutical products
06/15/1999US5912013 Drug delivery
06/15/1999US5912012 Effervescent systems with simplified packaging requirements
06/15/1999US5912011 Solvent system to be enclosed in capsules
06/15/1999US5912010 Prophylactic and therapeutic treatment of skin sensitization and irritation
06/15/1999US5912009 Fatty acid esters of glycolic acid and its salts
06/15/1999US5912008 Laminated structure of backing layer, moisture and impermeable layer, tackifiers and permeation enhancer
06/15/1999US5912007 Delivery system for the localized administration of medicaments to the upper respiratory tract and methods for preparing and using same
06/15/1999US5912006 Analgesics for menstruation pain
06/15/1999US5912005 Methods of use of uncoated gel particles
06/15/1999US5911972 Stable microbubbles suspensions injectable into living organisms
06/15/1999US5911966 High surface area alumina solid
06/15/1999US5911704 For delivering a pre-selected molecule into systemic circulation
06/15/1999CA2201749C Stable aqueous alfa interferon solution formulations
06/15/1999CA2161641C Stable, ingestable and absorbable nadh and nadph therapeutic compositions
06/15/1999CA2137363C Use of zona pellucida glycoproteins for immunocontraception
06/10/1999WO1999027990A2 Stereospecific delivery of a drug using electrotransport
06/10/1999WO1999027983A1 A ONE DOSE SYRINGE, COMPRISING A FREEZE-DRIED PROTEIN COMPOSITION, FOR ADMINISTERING OF A VOLUME LESS THAN 0.5 ml
06/10/1999WO1999027981A1 Automatic liquid injection system and method
06/10/1999WO1999027967A1 Therapeutic agents
06/10/1999WO1999027961A1 Transdermal delivery of particulate vaccine compositions
06/10/1999WO1999027960A1 Vaccine compositions for mucosal administration comprising chitosan
06/10/1999WO1999027954A2 Mixed lipopeptide micelles for inducing an immune response
06/10/1999WO1999027950A1 Compositions of leukaemia inhibitory factor
06/10/1999WO1999027949A1 METHOD OF SUPPRESSING β-AMYLOID-RELATED CHANGES IN ALZHEIMER'S DISEASE
06/10/1999WO1999027946A1 Pharmaceutical composition comprising cyclosporin solid-state microemulsion
06/10/1999WO1999027944A1 Prevention and treatment of amyloidogenic disease
06/10/1999WO1999027941A1 Oral antioxidant preparation comprising selenium and reduced glutathione
06/10/1999WO1999027940A1 Formulations for topical treatment of skin infections
06/10/1999WO1999027922A1 The use of polyols in combating yeast infection and polyol preparations for said use
06/10/1999WO1999027918A1 Microparticles for drug delivery across mucosa and the blood-brain barrier
06/10/1999WO1999027917A1 Medicament preparation in the form of a tablet or pellet for acid-labile active substances
06/10/1999WO1999027916A2 Method for producing solid dosing forms
06/10/1999WO1999027915A1 Masking agent in powder form for pharmaceutical flavours
06/10/1999WO1999027914A1 A pharmaceutical formulation of monoquaternary 2,16-bispiperidinylandrostane for intramuscular administration
06/10/1999WO1999027913A1 Polyethylene glycol matrix pellets for greasy, oily or sticky drug substances
06/10/1999WO1999027912A1 Porous hydroxyapatite particles as carriers for drug substances
06/10/1999WO1999027911A1 Soft-pellet drug and process for the preparation thereof
06/10/1999WO1999027910A1 Microsphere reservoirs for controlled release application
06/10/1999WO1999027909A1 Method for producing solid dosing forms
06/10/1999WO1999027908A1 Combined chemo-immunotherapy with liposomal drugs and cytokines
06/10/1999WO1999027907A1 Improved method for avoiding the degradation of an active principle